好醫(yi)生集(ji)團自創立之初就把“科技創新”放(fang)在重要(yao)的位(wei)置，已(yi)建立起較為完(wan)善的科研系統。

研(yan)(yan)(yan)(yan)(yan)(yan)發(fa)(fa)(fa)中(zhong)(zhong)心(xin)(xin)(xin)是集團的(de)重要職能部門(men)，以(yi)市場為導向，選擇(ze)有(you)效(xiao)、安全(quan)的(de)品種作為研(yan)(yan)(yan)(yan)(yan)(yan)發(fa)(fa)(fa)目標，承擔(dan)著中(zhong)(zhong)藥(yao)(yao)(yao)制劑、化藥(yao)(yao)(yao)原料及(ji)制劑、保健(jian)食(shi)品的(de)研(yan)(yan)(yan)(yan)(yan)(yan)發(fa)(fa)(fa)，致(zhi)力于腫(zhong)瘤、消化、心(xin)(xin)(xin)血(xue)管、內(nei)分泌等(deng)疾病領域的(de)新藥(yao)(yao)(yao)研(yan)(yan)(yan)(yan)(yan)(yan)究(jiu)(jiu)和(he)開發(fa)(fa)(fa)。集團成(cheng)立(li)了“科(ke)(ke)研(yan)(yan)(yan)(yan)(yan)(yan)總(zong)部”暨“神(shen)農-阿波羅藥(yao)(yao)(yao)物研(yan)(yan)(yan)(yan)(yan)(yan)究(jiu)(jiu)中(zhong)(zhong)心(xin)(xin)(xin)，下(xia)轄SLS-DDA、DDH、DDZ、DDW、DDC、HKB六大(da)(da)技術(shu)平臺(tai)，建立(li)起藥(yao)(yao)(yao)物的(de)發(fa)(fa)(fa)現(xian)、藥(yao)(yao)(yao)效(xiao)非臨床評價、藥(yao)(yao)(yao)學(xue)(xue)研(yan)(yan)(yan)(yan)(yan)(yan)究(jiu)(jiu)、安全(quan)研(yan)(yan)(yan)(yan)(yan)(yan)究(jiu)(jiu)及(ji)臨床研(yan)(yan)(yan)(yan)(yan)(yan)究(jiu)(jiu)等(deng)新藥(yao)(yao)(yao)研(yan)(yan)(yan)(yan)(yan)(yan)發(fa)(fa)(fa)體系。現(xian)有(you)各(ge)(ge)(ge)類(lei)高(gao)素質(zhi)研(yan)(yan)(yan)(yan)(yan)(yan)發(fa)(fa)(fa)人員及(ji)專家顧問300余人，其(qi)中(zhong)(zhong)50%以(yi)上(shang)具有(you)碩士學(xue)(xue)歷，包(bao)括杰青、外(wai)籍(ji)專家、海歸等(deng)各(ge)(ge)(ge)類(lei)人才。研(yan)(yan)(yan)(yan)(yan)(yan)發(fa)(fa)(fa)中(zhong)(zhong)心(xin)(xin)(xin)依靠(kao)集團每年固定的(de)科(ke)(ke)研(yan)(yan)(yan)(yan)(yan)(yan)經費投(tou)入，配備了各(ge)(ge)(ge)類(lei)世界先進(jin)儀器科(ke)(ke)研(yan)(yan)(yan)(yan)(yan)(yan)設備。研(yan)(yan)(yan)(yan)(yan)(yan)發(fa)(fa)(fa)中(zhong)(zhong)心(xin)(xin)(xin)堅持產(chan)、學(xue)(xue)、研(yan)(yan)(yan)(yan)(yan)(yan)結合，與國內(nei)外(wai)包(bao)括北(bei)京(jing)(jing)大(da)(da)學(xue)(xue)、四(si)川(chuan)大(da)(da)學(xue)(xue)華西醫學(xue)(xue)中(zhong)(zhong)心(xin)(xin)(xin)、北(bei)京(jing)(jing)協和(he)醫院等(deng)20余家高(gao)校、科(ke)(ke)研(yan)(yan)(yan)(yan)(yan)(yan)院所及(ji)外(wai)包(bao)研(yan)(yan)(yan)(yan)(yan)(yan)究(jiu)(jiu)單位(wei)建立(li)密切的(de)合作關(guan)系。